Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

First-in-human trial results of RET targeted BLU-667

Prof Vivek Subbiah - MD Anderson Cancer Center, Houston, USA
First-in-human trial results of RET targeted BLU-667 ( Prof Vivek Subbiah - MD Anderson Cancer Center, Houston, USA )
25 Apr 2018

Treating RET alterations with novel therapy BLU-667

Prof Vivek Subbiah - MD Anderson Cancer Center, Houston, USA
Treating RET alterations with novel therapy BLU-667 ( Prof Vivek Subbiah - MD Anderson Cancer Center, Houston, USA )
25 Apr 2018

The importance of online patient groups and 'The ROS1ders'

Janet Freeman-Daily - The ROS1ders
The importance of online patient groups and 'The ROS1ders' ( Janet Freeman-Daily - The ROS1ders )
25 Apr 2018

Results from GOBACK: Non-chromosomal birth defects linked with cancer

Dr Jeremy Schraw - Baylor College of Medicine, Houston, USA
Results from GOBACK: Non-chromosomal birth defects linked with cancer ( Dr Jeremy Schraw - Baylor College of Medicine, Houston, USA )
25 Apr 2018

A link between non-chromosomal birth defects and cancer

Dr Jeremy Schraw - Baylor College of Medicine, Houston, USA
A link between non-chromosomal birth defects and cancer ( Dr Jeremy Schraw - Baylor College of Medicine, Houston, USA )
25 Apr 2018

Novel gene biomarkers in multiple cancers derived from non-malignant breast phenotypes

Jon Obenauer - Rancho BioSciences, Rancho Santa Fe, USA
Novel gene biomarkers in multiple cancers derived from non-malignant breast phenotypes ( Jon Obenauer - Rancho BioSciences, Rancho Santa Fe, USA )
25 Apr 2018

Clinical development and economic prospects of CAR T cell immunotherapies

Dr Bob Velamehr - Fate Therapeutics, La Jolla, USA
Clinical development and economic prospects of CAR T cell immunotherapies ( Dr Bob Velamehr - Fate Therapeutics, La Jolla, USA )
25 Apr 2018

Theranostic imaging of lymphoma using radiolabelled αCD19-antibodies

Dr Dominik Sonanini - Tübingen University Hospital, Tübingen, Germany
Theranostic imaging of lymphoma using radiolabelled αCD19-antibodies ( Dr Dominik Sonanini - Tübingen University Hospital, Tübingen, Germany )
25 Apr 2018

Response and safety profile of neoadjuvant nivolumab for resectable lung cancer

Dr Drew Pardoll - Johns Hopkins Medicine, Baltimore, USA
Response and safety profile of neoadjuvant nivolumab for resectable lung cancer ( Dr Drew Pardoll - Johns Hopkins Medicine, Baltimore, USA )
25 Apr 2018

Doubled survival in metastatic lung cancer with combination therapy

Dr Leena Gandhi - NYU Langone Medical Center, New York, USA
Doubled survival in metastatic lung cancer with combination therapy ( Dr Leena Gandhi - NYU Langone Medical Center, New York, USA )
25 Apr 2018

Combined immuno-chemotherapy improves survival and responses in metastatic lung cancer

Dr Leena Gandhi - NYU Langone Medical Center, New York, USA
Combined immuno-chemotherapy improves survival and responses in metastatic lung cancer ( Dr Leena Gandhi - NYU Langone Medical Center, New York, USA )
25 Apr 2018

Results from CheckMate-227 : Immune combination reaches PFS endpoint

Dr Matthew Hellmann - Memorial Sloan Kettering Cancer Center, New York, USA
Results from CheckMate-227 :  Immune combination reaches PFS endpoint ( Dr Matthew Hellmann - Memorial Sloan Kettering Cancer Center, New York, USA )
25 Apr 2018